In the context of cancer research, the term "underpowered" refers to a study or clinical trial that lacks sufficient statistical power to reliably detect a meaningful effect. The statistical power of a study is the probability that it will detect an effect if there is one to be detected. An underpowered study has a higher risk of producing a false negative result, meaning it might fail to identify a treatment benefit even if one exists.
